Medicine Atlas

How Healing Is Practiced
Sign In
Text size
100%
Theme
Healer

Friedrich Fehleisen

Immunologists and Infectious Disease Specialists

Friedrich Fehleisen (1854 to 1924) was a German surgeon whose work focused on streptococcal bacteria. Born in Reutlingen in Wurttemberg, he died in San Francisco, California. In 1883 he became the first person to identify the bacterium Streptococcus pyogenes as the cause of erysipelas, and he did so by culturing the organism from erysipelas lesions taken from human patients. A year later Rosenbach described the same organism and gave it the name Streptococcus pyogenes, and later work by Friedrich Loeffler tied it to scarlet fever. Fehleisen also appears in the early history of cancer immunotherapy. After Wilhelm Busch had inoculated a sarcoma patient with erysipelas, Fehleisen began injecting small doses of live bacteria into tumours, observed regression in many cases, and concluded that a fever had to be induced and maintained for it to work. His observations later inspired William Coley to develop Coley's toxins.

Facts
Birth Year
1854 1
Death Year
1924 1
Connections

Specialist In

Source Friedrich Fehleisen (source article)
In the Other Atlases

Nationality

Also in Geography Atlas: the nationality of this subject.

Source Friedrich Fehleisen (source article)Lead sentence
Quote, Lead sentence
was a German surgeon whose work focused on streptococcal bacteria
Sources
1. Friedrich Fehleisen (source article)
  • Lead
    He was born in Reutlingen, Württemberg, in 1854
  • Lead [death-year]
    died in San Francisco, California, in 1924
  • Lead sentence
    was a German surgeon whose work focused on streptococcal bacteria
  • In Group: Pioneers of Bacteriology and Parasitology, S. pyogenes and erysipelas
    Fehleisen is notable as the first person to identify the cause of both erysipelas and scarlet fever as the bacterium Streptococcus pyogenes in 1883.
  • Specialist In: Surgery, Lead [specialist-in]
    was a German surgeon whose work focused on streptococcal bacteria
View the Source
Comments (0)
No comments yet. Be the first to share a thought.
Reader Challenges (0)
No disputes yet. Spotted an error or a better source? Open the first one.